Nemaura Medical Inc. (NMRD)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 01:57PM EDT
| Previous Close | 0.0385 |
| Open | 0.0460 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0422 - 0.0470 |
| 52 Week Range | 0.0330 - 1.2500 |
| Volume | |
| Avg. Volume | 40,470 |
| Market Cap | 1.243M |
| Beta (5Y Monthly) | -0.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Nemaura (NMRD) to Expand in UK With Metabolic Health Program
The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.
- Simply Wall St.
Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
Nemaura Medical ( NASDAQ:NMRD ) First Half 2024 Results Key Financial Results Net loss: US$3.81m (loss narrowed by 52...
- Zacks
Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.